Sunday, May 19, 2024

Waiting for new drugs for rare disorders in Canada

This series by MLI senior fellows John Adams and Nigel Rawson is an in-depth look at the disadvantages faced by Canadians with rare disorders in accessing needed, innovative drugs.

Top News

Inside Policy

Multimedia